FMOC-L-LYS (OCT-(OTBU)-GLU-(OTBU)-AEEA-AEEA)-OH
UNII K6W5NJ5JYJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Fmoc-l-lys (oct-(otbu)-glu-(otbu)-aeea-aeea)-oh, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K6W5NJ5JYJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1662688-20-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K6W5NJ5JYJ

CAS Registry Number

1662688-20-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FMOC-L-LYS (OCT-(OTBU)-GLU-(OTBU)-AEEA-AEEA)-OH

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C64H101N5O16

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

COTQASXXEXJBOM-PJYGOTMFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

145915290

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(OC(N[C@@H](CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](NC(CCCCCCCCCCCCCCCCC(OC(C)(C)C)=O)=O)C(OC(C)(C)C)=O)=O)=O)=O)C(O)=O)=O)C1c2c(-c3c1cccc3)cccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fmoc-l-lys (oct-(otbu)-glu-(otbu)-aeea-aeea)-oh. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

FMOC-L-LYS (OCT-(OTBU)-GLU-(OTBU)-AEEA-AEEA)-OH

Systematic Nomenclature

(2S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-6-((2-(2-(2-((2-(2-(2-(((4S)-5-((2-METHYLPROPAN-2-YL)OXY)-4-((18-((2-METHYLPROPAN-2-YL)OXY)-18-OXOOCTADECANOYL)AMINO)-5-OXOPENTANOYL)AMINO)ETHOXY)ETHOXY)ACETYL)AMINO)ETHOXY)ETHOXY)ACETYL)AMINO)HEXANOIC ACID

SYS

(3S,30S)-3-CARBOXY-30-((1,1-DIMETHYLETHOXY)CARBONYL)-9,18,27,32-TETRAOXO-49-(1,1-DIMETHYLETHYL) 1-(9H-FLUOREN-9-YLMETHYL)-11,14,20,23-TETRAOXA-2,8,17,26,31-PENTAAZANONATETRACONTANEDIOIC ACID ESTER

SYS

11,14,20,23-TETRAOXA-2,8,17,26,31-PENTAAZANONATETRACONTANEDIOIC ACID, 3-CARBOXY-30-((1,1-DIMETHYLETHOXY)CARBONYL)-9,18,27,32-TETRAOXO-, 49-(1,1-DIMETHYLETHYL) 1-(9H-FLUOREN-9-YLMETHYL) ESTER, (3S,30S)-

SYS

49-(1,1-DIMETHYLETHYL) 1-(9H-FLUOREN-9-YLMETHYL) (3S,30S)-3-CARBOXY-30-((1,1-DIMETHYLETHOXY)CARBONYL)-9,18,27,32-TETRAOXO-11,14,20,23-TETRAOXA-2,8,17,26,31-PENTAAZANONATETRACONTANEDIOATE

SYS

External Clinical & Regulatory Resources

Previous UNIIK6W4V7UP8J

Next UNIIK6W7P9KDK8